Premium
Gain of chromosome 7, as detected by in situ hybridization, strongly correlates with shorter survival in astrocytoma grade 2
Author(s) -
Wessels Peter H.,
Twijnstra Albert,
Kessels Alfons G. H.,
KrijneKubat Bela,
Theunissen Paul H.,
Ummelen Monique I. J.,
Ramaekers Frans C. S.,
Hopman Anton H.
Publication year - 2002
Publication title -
genes, chromosomes and cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.754
H-Index - 119
eISSN - 1098-2264
pISSN - 1045-2257
DOI - 10.1002/gcc.10029
Subject(s) - polysomy , monosomy , trisomy , aneuploidy , biology , pathology , astrocytoma , fluorescence in situ hybridization , karyotype , in situ hybridization , chromosome , chromosome 7 (human) , cancer research , glioma , medicine , genetics , gene expression , gene
The clinical course of astrocytoma grade 2 (A2) is highly variable and is not reflected by morphological characteristics. Earlier studies using small series of A2 cases suggest that in situ hybridization (ISH) with chromosome‐specific DNA probes allows for frequent detection of aneusomy 1, trisomy 7, and monosomy 10. The role of trisomy 7 in astrocytoma carcinogenesis is disputed, however, because of its presence in non‐neoplastic brain tissue, as detected by karyotyping. Our objective was to investigate whether there was a correlation between chromosomal aberrations and survival in a series of 47 cases of A2. All cases were evaluated for numerical aberrations of chromosomes 1, 7, and 10 by ISH. Chromosomal aberrations were detected in 68% of cases of A2. Trisomy/polysomy 7 was seen in 31 cases (66%), 22 of which (47%) had a high percentage of this numerical aberration. Only 11 of these 22 cases also showed aneusomy for 1 or 10. No cells or only a few cells with aberrations were detected in non‐neoplastic control samples. Using Kaplan‐Meier analysis, trisomy/polysomy 7 correlated significantly with shorter survival. Hence, as determined by ISH, trisomy/polysomy 7 is absent in non‐neoplastic brain tissue and is frequently detected in A2, correlating with the malignant progression of the disease. © 2002 Wiley‐Liss, Inc.